Copyright
©The Author(s) 2025.
World J Clin Cases. Sep 26, 2025; 13(27): 108391
Published online Sep 26, 2025. doi: 10.12998/wjcc.v13.i27.108391
Published online Sep 26, 2025. doi: 10.12998/wjcc.v13.i27.108391
Table 1 Six promising biodegradable stents
Ref. | Stent type | Material composition | Degradation time | Clinical advantages | Application scenarios |
Battistel et al[12] | PDO stent | PPDX | Medium degradation (approximately 20 days) | Great biocompatibility, moderate mechanical strength | Used for benign biliary strictures, technical success rate of 98%-100% |
Zhang et al[8] | PLA stent | PLA | Slow degradation (11 weeks) | Long degradation cycle, suitable for long-term support | Patency time significantly better than PDO stents |
Kim et al[10] | PCL stent | Polycaprolactone mixed with barium sulfate (3D printed) | Degradation rate adjustable via 3D printing | Supports personalized design, excellent radiopacity | Prevention of postoperative biliary strictures |
Peng et al[15] | Magnesium alloy stent | Degradable magnesium (Mg) | Degradation time not specified, combines drainage and anti-cancer functions | Antibacterial, anti-tumor effects | Experiments show it can induce apoptosis in gallbladder cancer cells |
Pan et al[16] | CS stent | Chitosan mixed with contrast agent (3D printed) | Potential for rapid degradation | Great biocompatibility | In development for pancreatic duct stents, biliary applications to be explored |
Guerra et al[17] | Composite Stent | E.g., PLA/PDO blends, drug-coated stents | Adjusted based on material combination (e.g., PLA+PDO achieves varying degradation rates) | Multifunctional (e.g., drug release, anti-bile adhesion) | Anti-bile adhesion coatings, drug delivery |
- Citation: Zhang LB, Wang Y, Yang XJ. Bioresorbable biliary stents: A step forward. World J Clin Cases 2025; 13(27): 108391
- URL: https://www.wjgnet.com/2307-8960/full/v13/i27/108391.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v13.i27.108391